首页 / 院系成果 / 成果详情页

Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia 会议论文 期刊论文

编号：

23af76b1-5eea-4904-b84d-529180ba13db
作者：

Chang, LungJi#^[1]Dong, Lujia^[2];Guo, HaoHsiang^[1];Zhang, JianPing^[3];Gao, ZhiYung^[2];Li, WeiDa^[2];Cui, Jiuwei(崔久嵬)^[4]Li, Wei(李薇)^[4]Lu, Daopei^[2];
语种：

英文
期刊：

MOLECULAR THERAPY ISSN：1525-0016 2014 年 22 卷 (S296 - S297) ; MAY
收录：
推荐引用方式
GB/T 7714：

Chang Lung-Ji,Dong Lujia,Guo Hao-Hsiang, et al. Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia [J].MOLECULAR THERAPY,2014,22:S296-S297.
APA：

Chang Lung-Ji,Dong Lujia,Guo Hao-Hsiang,Zhang Jian-Ping,&Lu Daopei.(2014).Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia .MOLECULAR THERAPY,22:S296-S297.
MLA：

Chang Lung-Ji, et al. "Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia" .MOLECULAR THERAPY 22(2014):S296-S297.

浏览次数：56  下载次数：0

浏览次数：56

下载次数：0

打印次数：0

Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia 会议论文期刊论文